New drugs could have hope for Alzheimer's

10/31/2003 | Los Angeles Times (tiered subscription model)

Ampakines, a new type of drug being developed by Cortex Pharmaceuticals, could hold promise for the treatment and prevention of Alzheimer's disease and other deteriorations in memory. The drugs work by boosting glutamate, a chemical that helps transmit electrical signals between brain cells.

View Full Article in:

Los Angeles Times (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
White Plains, NY
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ